Send us Feedback

Targeted Genetics (TGEN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

TGEN » Topics » Research and Development Expenses

These excerpts taken from the TGEN 10-K filed Mar 31, 2009.

Research and Development Expenses

Research and development expenses were $15.2 million in 2008, $17.7 million in 2007 and $14.5 million in 2006.

 

9

Table of Contents

Research and
Development Expenses

Research and development expenses were $15.2 million in 2008, $17.7 million in 2007 and $14.5 million in
2006.

 


9






Table of Contents


These excerpts taken from the TGEN 10-K filed Mar 25, 2008.

Research and Development Expenses

Research and development expenses were $17.7 million in 2007, $14.5 million in 2006 and $18.2 million in 2005.

Research and Development Expenses



Research and development expenses were $17.7 million in 2007, $14.5 million in 2006 and $18.2 million in 2005.



EXCERPTS ON THIS PAGE:

10-K (2 sections)
Mar 31, 2009
10-K (2 sections)
Mar 25, 2008

RELATED TOPICS for TGEN:

"Research and Development Expenses" elsewhere:

ACADIA Pharmaceuticals (ACAD)
Affymax (AFFY)
ARIAD Pharmaceuticals (ARIA)
BioCryst Pharmaceuticals (BCRX)
Cerus (CERS)
Cytokinetics (CYTK)
EPIX Pharmaceuticals (EPIX)
EXACT Sciences (EXAS)
GENETIC TECHNOLOGIES (GENE)
GPC Biotech AG (GPCB)
Idenix Pharmaceuticals (IDIX)
ImmunoGen (IMGN)
Iomai (IOMI)
InterMune (ITMN)
Metabasis Therapeutics (MBRX)
Memory Pharmaceuticals (MEMY)
Neurobiological Technologies (NTII)
Osiris Therapeutics (OSIR)
Protalix BioTherapeutics (PLX)
Sangamo BioSciences (SGMO)
Savient Pharmaceuticals (SVNT)
Theravance (THRX)
Trubion Pharmaceuticals (TRBN)
Targacept (TRGT)
SYNAGEVA BIOPHARMA CORP (TRMS)
Vical (VICL)
Vanda Pharmaceuticals (VNDA)
XenoPort (XNPT)
XOMA (XOMA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki